Connecting to SEC EDGAR… PricingSign in
← All filings

OCGN

Ocugen, Inc. SEC filings
Biological Products, (No Diagnostic Substances) · Nasdaq · Incorporated in DE
On the radar right now · 0
Nothing in the live feed for OCGN right now.
Filing history
2026-11-06
Proxy material DEFA14A
Filing ↗
2026-11-06
Proxy material DEFA14A
Filing ↗
2026-11-04
Quarterly report 10-Q
Filing ↗
2026-11-04
Current report 8-K
Earnings results
Filing ↗
2026-10-15
Current report 8-K
Reg FD disclosure
Filing ↗
2026-10-15
Current report 8-K
Material agreementReg FD disclosureOther event
Filing ↗
2026-10-13
Insider trade 4
Filing ↗
2026-10-09
Planned insider sale 144
Filing ↗
2026-10-06
Current report 8-K
Shareholder vote
Filing ↗
2026-09-23
Current report 8-K
Shareholder vote
Filing ↗
2026-09-11
Insider trade 4
Filing ↗
2026-09-09
Planned insider sale 144
Filing ↗
2026-09-08
Current report 8-K
Reg FD disclosureOther event
Filing ↗
2026-08-14
Proxy material DEFA14A
Filing ↗
2026-08-13
Passive 5%+ stake update SCHEDULE 13G/A
Filing ↗
2026-08-07
Passive 5%+ stake SCHEDULE 13G
Filing ↗
2026-08-06
Quarterly report 10-Q
Filing ↗
2026-08-06
Current report 8-K
Earnings results
Filing ↗
2026-07-30
Proxy material DEFA14A
Filing ↗
2026-07-30
Proxy statement (shareholder vote) DEF 14A
Filing ↗
2026-07-29
Passive 5%+ stake SCHEDULE 13G
Filing ↗
2026-07-20
PRE 14A PRE 14A
Filing ↗
2026-07-13
Current report 8-K
Other event
Filing ↗
2026-06-17
Insider trade 4
Filing ↗
2026-06-15
Insider trade 4
Filing ↗
2026-06-15
Insider trade 4
Filing ↗
2026-06-15
Insider trade 4
Filing ↗
2026-06-15
Insider trade 4
Filing ↗
2026-06-15
Insider trade 4
Filing ↗
2026-06-11
Current report 8-K
Shareholder voteOther event
Filing ↗
2026-06-03
Current report 8-K
Exec/director change
Filing ↗
2026-05-14
Current report 8-K
Exec/director changeOther event
Filing ↗
2026-05-14
Current report 8-K
New debtShare sale (dilution)Reg FD disclosure
Filing ↗
2026-05-08
Quarterly report 10-Q
Filing ↗
2026-05-07
Current report 8-K
Material agreementAgreement endedEarnings resultsNew debtShare sale (dilution)
Filing ↗
2026-05-05
Current report 8-K
Earnings resultsOther event
Filing ↗
2026-05-04
Current report 8-K
Earnings resultsReg FD disclosureOther event
Filing ↗
2026-04-28
Proxy material DEFA14A
Filing ↗
2026-04-28
Annual report to shareholders ARS
Filing ↗
2026-04-28
Proxy statement (shareholder vote) DEF 14A
Filing ↗